Tolerability of risk approach and the management of pharmaceutical risks.
نویسندگان
چکیده
Public trust in policy makers, industry officials and opinion shapers is declining in Western societies, a trend highlighted by opinion polls, surveys and research [1–4,101], which leads to political crisis, substantial economic losses and the introduction of controversial riskregulation practices, such as the precautionary principle [5–8]. Is the post-Vioxx pharmaceutical model of risk regulation immune to such developments? The tolerability of risk (ToR) framework constitutes a model of consensus regulation successfully used by the UK regulator of health and safety to help make decisions concerning risk [9]. It has been recently considered to offer a promising heuristic for improving the quality of public health decisions [10]. How much could the pharmaceutical sector learn from the ToR approach?
منابع مشابه
Risk management in medical product development process using traditional FMEA and fuzzy linguistic approach: a case study
Medical product development (MPD) process is highly multidisciplinary in nature, which increases the complexity and the associated risks. Managing the risks during MPD process is very crucial. The objective of this research is to explore risks during MPD in a dental product manufacturing company and propose a model for risk mitigation during MPD process to minimize failure events. A case study ...
متن کاملDeveloping a Suitable Model for Supplier Selection Based on Supply Chain Risks: An Empirical Study from Iranian Pharmaceutical Companies
The supply chain represents the critical link between the development of new product and the market in pharmaceutical industry. Over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. In addition, powerful regulatory and market forces have provided new incentives for pharmaceutical firms to basically rethink the wa...
متن کاملDeveloping a Suitable Model for Supplier Selection Based on Supply Chain Risks: An Empirical Study from Iranian Pharmaceutical Companies
The supply chain represents the critical link between the development of new product and the market in pharmaceutical industry. Over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. In addition, powerful regulatory and market forces have provided new incentives for pharmaceutical firms to basically rethink the wa...
متن کاملGreen Supply Chain Risk Network Management and Performance Analysis: Bayesian Belief Network Modeling
With the increase in environmental awareness, competitions and government policies, implementation of green supply chain management activities to sustain production and conserve resources is becoming more necessary for different organizations. However, it is difficult to successfully implement green supply chain (GSC) activities because of the risks involved. These risks alongside their resourc...
متن کاملA New Approach to Project Risk Responses Selection with Inter-dependent Risks
Risks are natural and inherent characteristics of major projects. Risks are usually considered independently in analysis of risk responses. However, most risks are dependent on each other and dependent risks are rare in the real world. This paper proposes a model for proper risk response selection from the responses portfolio with the purpose of optimization of defined criteria for projects. Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Expert review of clinical pharmacology
دوره 1 2 شماره
صفحات -
تاریخ انتشار 2008